China CDE Approves Global Phase III Study

Business

China CDE Approves Global Phase III Study of Olverembatinib for SDH-Deficient GIST

SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 — Ascentage Pharma (6855.HK), a global biopharmaceutical…

Technology

AVer’s TR535N Wins 2025 EdTech Breakthrough Award for Video Capture Innovation

Business

Buy International Homes at the Global Property Expo, Singapore

Business

hubergroup Print Solutions launches water-based inks and varnishes for direct food contact

Technology

AAEON’s NanoCOM-MTU Hosts 28W Intel Core Ultra CPUs on the COM Express Type 10 Form Factor

Technology

MOTOR Ai Secures $20M to Accelerate Global Rollout of Safe Autonomous Driving Software